WAM
IRWD icon

Watershed Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Watershed Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23,108
Closed -$246K – 131
2023
Q2 		$246K Buy
+23,108
New +$248K 0.3% 85
2023
Q1 		– Sell
-23,366
Closed -$290K – 135
2022
Q4 		$290K Buy
+23,366
New +$265K 0.37% 19
2022
Q1 		– Sell
-23,535
Closed -$274K – 133
2021
Q4 		$274K Buy
+23,535
New +$289K 0.25% 84

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Watershed Asset Management's IRWD Position: Q3 2023 in Review

Watershed Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 23,108 shares — an estimated $246K sold.

Watershed Asset Management first reported a position in IRWD in Q4 2021 and held it in 3 quarters. The position peaked at $290K in Q4 2022. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

  • Watershed Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Watershed Asset Management sold 23,108 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $246K.
  • Watershed Asset Management first reported a position in Ironwood Pharmaceuticals in Q4 2021 and held it in 3 quarters.
  • Watershed Asset Management's Ironwood Pharmaceuticals position peaked at $290K in Q4 2022.
  • 248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Watershed Asset Management's 13F filing for Q3 2023, filed 30 Oct 2023.